Condition: Vitamin D Deficiency Due to Chronic Kidney Disease · Sponsor: Medical University of Gdansk
The goal of this observational study is to learn about the effects of cholecalciferol administration, according to guidelines for the general population, on laboratory parameters of Chronic Kidney Disease-Mineral and Bone Disorder in dialysis patients, depending of the attained levels of vitamin D (25OH)D). The main question it aims to answer is: How does cholecalciferol affect calcium and phosphate metabolism parameters depending on the achieved levels of 25(OH)D? Participants taking cholecalciferol as part of their regular medical care for CKD-MBD will have the laboratory result parameters observed for up to 4 years.
This description comes directly from the study's public registry record.
Leszek Tylicki, Prof. · + 48 58 584 47 00 · leszek.tylicki@gumed.edu.pl
Agnieszka Tarasewicz, MD; PhD · ataras@gumed.edu.pl
Always discuss trial participation with your own doctor first.
| Medical University of Gdansk | Gdansk, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06571344